Understanding Myeloma News About Secondary Cancers and Clotting

Published on

Topics include: Treatment and Understanding

Dr. James Berenson helps patients understand a new FDA investigation regarding the use of lenalidomide (Revlimid) and thalidomide and a possible higher risk of second cancers, he comments on a new study from Sweden regarding increased risk of blood clots among myeloma patients, and he also previews the topics that he believes will be important for patients at the upcoming ASCO conference.

View more programs featuring

Produced in association with

Related Programs

New Arsenal of Drugs Fighting Myeloma

Dr. Paul Richardson provides an update on drug development from ASCO 2012


ASCO Myeloma Update: More Promising Medicines on the Way

Dr. James Berenson gives his perspective on the latest drug development updates from ASCO 2012


A New Backbone Therapy in the Future Myeloma Treatment

Research is showing that proteasome inhibitors are incredibly effective at treating many stages of myeloma. Dr. Shaji Kumar talks about how this therapy is becoming a new backbone treatment for myeloma.


Join Our Community Register for Events Read Our Latest Blog

Page last updated on September 5, 2014